Citadel Advisors
DXTR

Citadel Advisors’s Dextera Surgical Inc. DXTR Stock Holding History

Citadel Advisors’s Portfolio DXTR Stock Details DXTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-67,208
Closed -$19K – 8787
2017
Q3 		$19K Sell
67,208
-76,009
-53% -$21.9K ﹤0.01% 7372
2017
Q2 		$43K Buy
+143,217
New +$72.5K ﹤0.01% 7136

Other funds holding DXTR

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Citadel Advisors's DXTR Position: Q4 2017 in Review

Citadel Advisors sold out of Dextera Surgical Inc. (DXTR) in Q4 2017, closing a stake of 67,208 shares — an estimated $19K sold.

Citadel Advisors first reported a position in DXTR in Q2 2017 and held it in 2 quarters. The position peaked at $43K in Q2 2017. 3 funds tracked by Wall St. Rank hold DXTR as of Q4 2017.

  • Citadel Advisors reported no remaining Dextera Surgical Inc. position as of Q4 2017 after selling out during the quarter.
  • Citadel Advisors sold 67,208 Dextera Surgical Inc. shares in Q4 2017, an estimated $19K.
  • Citadel Advisors first reported a position in Dextera Surgical Inc. in Q2 2017 and held it in 2 quarters.
  • Citadel Advisors's Dextera Surgical Inc. position peaked at $43K in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Dextera Surgical Inc. as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.